FTC sues important pharmacy profit supervisors more than insulin prices The agency brought action against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the listing price of lifestyle-preserving insulin medicines. Investment decision in digital health companies reached several years-reduced levels fina... https://dave-s-hot-chicken-nutrit61615.bloggosite.com/37265699/5-simple-techniques-for-healthcare-news